John P. McLaughlin
2015
In 2015, John P. McLaughlin earned a total compensation of $3.9M as President and Chief Executive Officer at PDL BioPharma, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,134,034 |
|---|---|
| Salary | $737,591 |
| Stock Awards | $984,510 |
| Other | $10,000 |
| Total | $3,866,135 |
McLaughlin received $2.1M in non-equity incentive plan, accounting for 55% of the total pay in 2015.
McLaughlin also received $737.6K in salary, $984.5K in stock awards and $10K in other compensation.
Rankings
In 2015, John P. McLaughlin's compensation ranked 2,275th out of 13,638 executives tracked by ExecPay. In other words, McLaughlin earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,275 out of 13,638 | 83rd |
Division Manufacturing | 818 out of 5,187 | 84th |
Major group Chemicals And Allied Products | 291 out of 1,857 | 84th |
Industry group Drugs | 230 out of 1,531 | 85th |
Industry Biological Products, Except Diagnostic Substances | 41 out of 260 | 84th |
Source: SEC filing on April 28, 2017.
McLaughlin's colleagues
We found five more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2015.
2015
Peter Garcia
PDL BioPharma
Chief Financial Officer
2015
Christopher Stone
PDL BioPharma
General Counsel
2015
Danny Hart
PDL BioPharma
Vice President, Business Development
2015
David Montez
PDL BioPharma
Chief Accounting Officer
2015
Steffen Pietzke
PDL BioPharma